Literature DB >> 17450421

Cytomegalovirus disease with Guillain-Barré syndrome in a cadaver renal allograft recipient: cause or coincidence.

Sai Ram R Keithi-Reddy1, Rajasekhara M Chakravarthi, Shaista M Hussaini, Rohini R Venkatapuram, J M K Murthy.   

Abstract

Anecdotal reports of acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) with cytomegalovirus (CMV) suggested as the etiological agent have been described in transplant recipients with poor prognosis. We describe a 48-year-old man, a cadaveric renal allograft recipient on cyclosporine, mycophenolate mofetil and prednisolone, who developed febrile illness with unexplained anemia followed by progressive weakness of the upper and lower limbs. He was diagnosed as a case of Guillain-Barré syndrome (GBS). His CMV serology was positive by polymerase chain reaction (PCR). We treated him with both gancyclovir and intravenous immunoglobulins within a week of the onset of GBS and observed rapid recovery. Thus, search for CMV is warranted in transplant patients presenting with GBS, as early initiation of treatment with gancyclovir and immunoglobulins can help expedite recovery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450421     DOI: 10.1007/s11255-007-9197-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Guillain-Barre syndrome in organ and bone marrow transplant patients.

Authors:  K R Bulsara; P W Baron; J E Tuttle-Newhall; P A Clavien; J Morgenlander
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

2.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

Review 3.  Neurological complications in kidney transplant recipients.

Authors:  Claudio Ponticelli; Maria Rosaria Campise
Journal:  J Nephrol       Date:  2005 Sep-Oct       Impact factor: 3.902

Review 4.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

5.  Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group.

Authors:  L H Visser; P I Schmitz; J Meulstee; P A van Doorn; F G van der Meché
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

Review 6.  Guillain-Barré syndrome after solid organ transplantation.

Authors:  R A El-Sabrout; B Radovancevic; V Ankoma-Sey; C T Van Buren
Journal:  Transplantation       Date:  2001-05-15       Impact factor: 4.939

7.  Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation.

Authors:  V Rodriguez; I Kuehnle; H E Heslop; S Khan; R A Krance
Journal:  Bone Marrow Transplant       Date:  2002-03       Impact factor: 5.483

Review 8.  Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.

Authors:  N Yuki
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

Review 9.  Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.

Authors:  H P Hartung; J D Pollard; G K Harvey; K V Toyka
Journal:  Muscle Nerve       Date:  1995-02       Impact factor: 3.217

10.  Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.

Authors:  L H Visser; F G van der Meché; J Meulstee; P P Rothbarth; B C Jacobs; P I Schmitz; P A van Doorn
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

View more
  4 in total

Review 1.  Late-onset cytomegalovirus infection complicated by Guillain-Barre syndrome in a kidney transplant recipient: case report and review of the literature.

Authors:  E Shaban; R Gohh; B M Knoll
Journal:  Infection       Date:  2015-07-04       Impact factor: 3.553

Review 2.  Hematologic abnormalities following renal transplantation.

Authors:  Mark A Marinella
Journal:  Int Urol Nephrol       Date:  2009-03-20       Impact factor: 2.266

3.  Primary Cytomegalovirus Infection Causing Guillain-Barré Syndrome in a Living Renal Allograft Recipient.

Authors:  Massini Merzkani; Ezra Israel; Mala Sachdeva
Journal:  Case Rep Transplant       Date:  2017-11-20

4.  Guillain-Barre syndrome: a typical paraneoplastic syndrome in a kidney transplant recipient with allograft renal cell carcinoma: a case report and review of the literature.

Authors:  Izabela Zakrocka; Iwona Baranowicz-Gąszczyk; Agnieszka Korolczuk; Wojciech Załuska
Journal:  BMC Nephrol       Date:  2020-10-14       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.